Compass Course: Efficacy Study

Status:	Active, not recruiting
Conditions:	Breast Cancer, Cancer
Therapuetic Areas:	Oncology
Healthy:	No
Age Range:	25 - Any
Updated:	2/22/2019
Start Date:	March 2, 2018
End Date:	March 31, 2020

The Compass Course is an 8-session progressive structure that was developed based on
theoretical and scientific evidence from psychology and occupational therapy. The goal of the
intervention is to provide participants with information, tools, and support that help them
move towards reclaiming a sense of self-grounded purpose in daily life. The study will use a
convenience sample of breast cancer survivors to evaluate the efficacy of the Compass Course
intervention.

Inclusion criteria:

1. 25 years of age or older

2. Completed treatment (such as chemotherapy, radiation, surgery) for Stage 0, 1, 2, or 3
breast cancer at least 2 months prior to participating in the Compass Course
intervention

3. English speaking

4. High school diploma or GED

5. Able to see, hear, speak (with or without assistive devices)

6. Able to provide own transportation to sessions

7. Willing and able to commit to attend all 8 intervention sessions

Exclusion criteria (all self-reported):

1. Stage 4 breast cancer or any other stage 4 cancer

2. Actively receiving chemotherapy or radiation treatments for cancer. (However, patients
may be on Herceptin and/or endocrine treatment and participate in the study.)

3. History of neurologic disorder (such as stroke or brain injury) with residual
impairments that likely interfere with learning

4. Any medical condition (physical or mental health) that interferes with the performance
of everyday activities and roles.

We found this trial at

sites

Abbott Northwestern Hospital

800 E 28th St
Minneapolis, Minnesota 55407

(612) 863-4000